LTFS
ADPT icon

Ladenburg Thalmann Financial Services’s Adaptive Biotechnologies ADPT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$34K Buy
1,117
+58
+5% +$1.67K ﹤0.01% 3793
2019
Q3 		$33K Buy
1,059
+843
+390% +$34.4K ﹤0.01% 3706
2019
Q2 		$10K Buy
+216
New +$9.57K ﹤0.01% 4419

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ladenburg Thalmann Financial Services's ADPT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Adaptive Biotechnologies (ADPT) stake by 5.5% in Q4 2019, buying an estimated $1.67K and bringing the position to 1,117 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #3793.

Ladenburg Thalmann Financial Services first reported a position in ADPT in Q2 2019 and has held it in 3 quarters since. 133 funds tracked by Wall St. Rank hold ADPT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,117 shares of Adaptive Biotechnologies worth $34K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 58 Adaptive Biotechnologies shares in Q4 2019, an estimated $1.67K.
  • Adaptive Biotechnologies made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3793 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Adaptive Biotechnologies in Q2 2019 and has held it in 3 quarters since.
  • 133 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.